AAAAAA
Results: 26-32/32
Authors:
Angulo, P
Dickson, ER
Therneau, TM
Jorgensen, RA
Smith, C
DeSotel, CK
Lange, SM
Anderson, ML
Mahoney, DW
Lindor, KD
Citation: P. Angulo et al., Comparison of three doses of ursodeoxycholic acid in the treatment of primary biliary cirrhosis: a randomized trial, J HEPATOL, 30(5), 1999, pp. 830-835
Authors:
Angulo, P
Bharucha, AE
Jorgensen, RA
DeSotel, CK
Sandborn, WJ
Larusso, NF
Lindor, KD
Citation: P. Angulo et al., Oral nicotine in treatment of primary sclerosing cholangitis - A pilot study, DIG DIS SCI, 44(3), 1999, pp. 602-607
Authors:
Angulo, P
Lindor, KD
Therneau, TM
Jorgensen, RA
Malinchoc, M
Kamath, PS
Dickson, ER
Citation: P. Angulo et al., Utilization of the Mayo risk score in patients with primary biliary cirrhosis receiving ursodeoxycholic acid, LIVER, 19(2), 1999, pp. 115-121
Authors:
Angulo, P
Dickson, ER
Citation: P. Angulo et Er. Dickson, Low-dose methotrexate in primary biliary cirrhosis - Reply, GASTROENTY, 117(6), 1999, pp. 1512-1513
Authors:
Angulo, P
Dickson, ER
Citation: P. Angulo et Er. Dickson, Methotrexate in the treatment of primary biliary cirrhosis: The hype and the hope, GASTROENTY, 117(2), 1999, pp. 492-495
Authors:
Angulo, P
Larson, DR
Therneau, TM
LaRusso, NF
Batts, KP
Lindor, KD
Citation: P. Angulo et al., Time course of histological progression in primary sclerosing cholangitis, AM J GASTRO, 94(11), 1999, pp. 3310-3313
Authors:
Angulo, P
Lindor, KD
Citation: P. Angulo et Kd. Lindor, Management of nonalcoholic steatohepatitis, CLIN G MED, 1999, pp. 367-379